Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

Journal of Neural Transmission

Volumn 105, Issue 4-5, 1998, Pages 415-422

  Hoyer, S ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Advanced glycation end products; Brain; Insulin; Insulin receptor; Non insulin dependent diabetes mellitus; Sporadic Alzheimer disease

Indexed keywords

AMYLOID BETA PROTEIN; GLUCOSE; INSULIN; INSULIN RECEPTOR;

ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; GLUCOSE METABOLISM; GLYCATION; HUMAN; NEUROFIBRILLARY TANGLE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AGE OF ONSET; ALZHEIMER DISEASE; BRAIN; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INSULIN; MODELS, NEUROLOGICAL; NEURONS; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0031928535     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050067     Document Type: Article

References (48)

1. Bak P, Tang C, Wiesenfeld K (1988) Self-organized criticality. Physic Rev A 38: 364-374
2. Blass JP, Gibson GE, Hoyer S (1997) Metabolism of the aging brain. Adv Cell Aging Gerontol 2: 109-128
3. Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A, Migheli A, Stern D (1993) Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143: 1699-1712
4. Brownlee M (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46: 223-234
5. Buccala R, Cerami A (1992) Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 23: 1-34
6. Bucht G, Adolfsson R, Lithner F, Winblad B (1983) Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med Scand 213: 387-392
7. Drachman DA, Noffsinger D, Sahakian BJ, Kurdziel S, Fleming P (1980) Aging, memory and the cholinergic system: a study of dichotonic listening. Neurobiol Aging 1: 39-43
8. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO (1989) Prevalence of Alzheimer's disease in a community population of older persons: higher that previously reported. J Am Med Assoc 262: 2551-2556
9. Frölich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalheimer A, Türk A, Hoyer S, Zöchling R, Boissl KW, Jellinger K, Riederer P (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm (this volume)
10. Fujisawa Y, Sasaki K, Akiyama K (1991) Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type. Biol Psychiatry 30: 1219-1228
11. Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonekura Y, Konishi J (1994) Altered cerebral energy metabolism in Alzheimer's disease. a PET study. J Nucl Med 35: 1-6
12. Gabuzda D, Buciglio J, Chen LB, Matsudaira P, Yankner BA (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269: 13623-13628
13. Hardy J (1997) The Alzheimer family of diseases: many etiologies, one pathogenesis? Proc Natl Acad Sci USA 94: 2095-2097
14. Harr SD, Simonian NA, Hyman BT (1995) Functional alterations in Alzheimer's disease: Decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. J Neuropathol Exp Neurol 54: 38-41
15. Held GA, Solina DH, Keane DT, Haag WJ, Horn PM, Grinstein G (1990) Experimental study of critical-mass fluctuations in an evolving sandpile. Phys Rev Lett 69: 1120-1123
16. Henneberg N, Hoyer S (1995) Desensitization of the neuronal insulin receptor: a new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Arch Gerontol Geriatr 21: 63-74
17. Hong M, Lee VMY (1997) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272: 19547-19553
18. Hoyer S (1992) Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol Chem Neuropathol 16: 207-224
19. Hoyer S (1993) Editor's note for debate. Sporadic dementia of Alzheimer type: role of amyloid in etiology is challenged. J Neural Transm [P-D Sect] 6: 159-165
20. Hoyer S (1994) Age as risk factor for sporadic dementia of the Alzheimer type? NY Acad Sci 179: 248-256
21. Hoyer S (1995) Age-related changes in cerebral oxidative metabolism. Implications for drug therapy. Drugs Aging 6: 210-218
22. Hoyer S (1997) Models of Alzheimer's disease: cellular and molecular aspects. J Neural Transm [Suppl] 49: 11-21
23. Hoyer S, Nitsch R (1989) Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type. J Neural Transm 75: 227-232
24. Hoyer S, Nitsch R, Oesterreich K (1991) Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient earl-onset cases. J Neural Transm [P-D Sect] 3: 1-14
25. Hoyer S, Müller D, Plaschke K (1994) Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism. J Neural Transm [Suppl] 44: 259-268
26. Lynch G, Baudry M (1984) The biochemistry of memory: a new and specific hypothesis. Science 224: 1057-1063
27. Manning CA, Raggozino M, Gold PE (1993) Glucose enhancement of memory in patients with Alzheimer's disease. Neurobiol Aging 14: 523-528
28. Münch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, Vlassara H, Smith MA, Perry G, Riederer P (1997) Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm (this volume)
29. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci USA 89: 1671-1675
30. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258: 304-307
31. Ott A, Breteler MMB, van Harskamp F, Clauss JJ, van der Cammen TJM, Grobbee DE, Hofman A (1995) Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study. Br J Med 310: 970-973
32. Pardridge WM, Boado RJ, Farrell CR (1990) Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. J Biol Chem 265: 18035-18040
33. Plaschke K, Müller D, Hoyer S (1996) Effects of adrenalectomy and corticosterone substitution on glucose and energy metabolism in rat brain. J Neural Transm 103: 89-100
34. Roder HM, Ingram VM (1991) Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios. J Neurosci 11: 3325-3343
35. Sapolsky RM, Krey LC, McEwen BS (1986) The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Res 7: 284-301
36. Seksek O, Biwersi J, Verkman AS (1995) Direct measurement of trans-Golgi pH in living cells and regulation by second messengers. J Biol Chem 270: 4967-4970
37. Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P (1994) Decreased concentrations of GLUT 1 and GLUT 3 glucose transporters in the brain of patients with Alzheimer's disease. Ann Neurol 35: 546-551
38. Slack BE, Breu J, Petryniak MA, Srivastava K, Wurtman RJ (1995) Tyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic actylcholine receptor. J Biol Chem 270: 8337-8344
39. Slack BE, Breu J, Muchnicki L, Wurtman RJ (1997) Rapid stimulation of amyloid precursor protein release by epidermal growth factor: role of protein kinase C. Biochem J 327: 245-249
40. Söderberg M, Edlund C, Kristensson K, Dallner G (1991) Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26: 421-425
41. Stephens DJ, Austen BM (1996) Metabolites of the β-amyloid protein generated by β-secretase localise to the trans-Golgi network and late endosome in 293 cells. J Neurosci Res 46: 211-225
42. Stolk RP, Breteler MMB, Ott A, Pols HAP, Lamberts SWJ, Grobbee DE, Hofman A (1997) Insulin and cognitive function in an elderly population. The Rotterdam study. Diabetes Care 20: 792-795
43. Swaab DF, Raadsheer FC, Endert EF, Hofman MA, Kamphorst W, Ravid R (1994) Increases of corticol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid. J Neuroendocrinol 6: 681-687
44. Verde C, Pascale MC, Martire G, Lotti LV, Torrisi MR, Helenius A, Bonatti S (1995) Effect of ATP depletion and DTT on the transport of membrane proteins from the endoplasmic reticulum and the intermediate compartment to the Golgi complex. Eur J Cell Biol 67: 267-274
45. Vlassara H, Bucala R, Striker L (1994) Biology of disease. Pathogenetic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70: 138-151
46. Wilde-Bode C, Yamazaki T, Capell A, Leimert U, Steiner H, Ihara Y, Haass C (1997) Intracellular generation and accumulation of amyloid β-peptide terminating at amino acid 42. J Biol Chem 272: 16085-16088
47. Wu Y, Sun FF, Tong DM, Taylor BM (1996) Changes in membrane-properties during energy depletion-induced cell injury studied with fluorescence microscopy. Biophys J 71: 91-100
48. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382:685-691